Di-mannosylation enhances adjuvant properties of adamantane-containing desmuramyl peptides in vivo

Marija Paurević,Aleksandra Maršavelski,Siniša Ivanković,Ranko Stojkovic,Rosana Ribic

DOI: https://doi.org/10.1039/d4ob00592a

2024-06-08

Organic & Biomolecular Chemistry

Abstract:Muramyl dipeptide (MDP) is the smallest essential peptidoglycan substructure capable of promoting both innate and adaptive immune responses. Herein, we report on the design, synthesis, in vivo study of the adjuvant properties and molecular dynamics (MD) simulation study of two nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) desmuramyl peptide agonists. An achiral adamantyl moiety and additionally one mannosyl subunit in derivative 7, and two mannosyl subunits in derivative 11, were introduced in order to access how the degree of mannosylation affects the immune response and NOD2 binding affinity, when compared to the reference ManAdDMP. Both novel DMPs showed improved immunomodulating properties, where compound 11 stands out with the highest increase in the total anti-OVA IgG production. MD simulations of NOD2 binding with derivatives 7 and 11 indicate better binding of derivative 11. The specific molecular interactions and energetics driving the binding of 7 and 11 to the NOD2 are also detailed here.

chemistry, organic